Archive for the ‘Strategic National Stockpile’ Category

Fuad el-Hibri, king of anthrax, wins an award from Ernst & Young

Marie-José Daoud
Awarded the Ernst and Young prize for Entrepreneur of the year 2009 in the Technology category for the Greater Washington region last June, Fuad El-Hibri is the CEO of Emergent Biosolutions, an American company that supplies the anthrax vaccine to the American government. He is in line for the national E&Y 2009 prize, which [...]

Emergent Biosolutions Delivers Over 3 Million Doses Of Biothrax® To U.S. Department Of Health And Human Services For Strategic National Stockpile

Delivery represents approximately $75 million of revenue for 4Q 2006; Company on track to deliver remaining 1 million doses in 1Q 2007—

GAITHERSBURG, MD, December 14, 2006—Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has successfully completed the 4Q 2006 deliveries of over three million doses of BioThrax® (Anthrax Vaccine Adsorbed), the only FDA licensed [...]